Position in MRNA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$172,384,025
+$52,618,099 QoQ
Shares Held
2,461,574
+4.4% QoQ
Ownership
0.617%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#23
of 777 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 0%
Shared 98%
None 2%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLINGTON MANAGEMENT GROUP LLP holds $14,994,233,945 across 206 Biotechnology names. MRNA ranks #25 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,247,658 | $1,613,209,155 | |
| 2 | ARGX |
Argenx SE
|
930,548 | $863,334,513 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,270,087 | $791,950,042 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,843,415 | $719,794,757 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,110,407 | $635,295,816 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
7,651,415 | $606,680,693 | |
| 7 | CYTK |
Cytokinetics Inc
|
6,931,770 | $590,517,483 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
825,714 | $443,367,129 |
All Filings in MRNA
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $172,384,025 | 2,461,574 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $119,765,926 | 2,357,597 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,456,369 | 83,295 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,235,509 | 86,547 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,070,629 | 38,805 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $82,088,981 | 2,895,555 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $162,789,523 | 3,915,092 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $349,165,696 | 5,224,685 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $512,830,305 | 4,318,571 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $597,237,148 | 5,604,703 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $718,583,828 | 7,225,579 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $579,572,479 | 5,611,119 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $623,892,536 | 5,134,918 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $659,201,449 | 4,292,235 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $768,228,270 | 4,276,964 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $557,087,691 | 4,711,101 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $624,447,202 | 4,371,349 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $52,284,523 | 303,521 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $106,389,677 | 418,890 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $16,592,850 | 43,114 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $35,342,868 | 150,408 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $2,791,591 | 21,318 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,314,126 | 12,579 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,987,366 | 28,090 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||